Business Standard

Parenteral plans Rs 50-cr expansion of Baddi unit

Shashikant Trivedi  |  New Delhi/ Bhopal 

  • ALSO READ

    LT Overseas to build modern mandis

    Discontent at Indore investors` meet

    Abhishek Industries to set up spinning plant in MP

    Netlink forays into remote monitoring

    MP keen on partners for Indore IT park

Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
 
"We enjoy an excise tax holiday for 10 years in Baddi. We have invested Rs 35 crore in the facility and are going to create an additional capacity with an investment of Rs 50 crore, including modernisation of our Indore units," said Anil Mittal, chief executive officer of the company.
 
PDIL started its unit in Indore to manufacture intravenous (IV) fluids in polypropylene bottles against glass bottles and further diversified into eye and ear drops and formulations (solid and liquid orals). The company set up its unit in Baddi industrial area last year for formulations; injectibles tablets and capsules.
 
"Since Indore is centrally located and freight does matter in IV fluid that is why we have decided to have our formulation unit in Baddi and IV fluid unit in Indore," he added.
 
The IV fluid is an excise free commodity. He also said that his company was gauging potential in export market.
 
"Currently 10-15 per cent of our business comes from exports but we are looking at some international-level recognition for our products," Mittal further said.

 

Parenteral plans Rs 50-cr expansion of Baddi unit

Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
Parenteral Drugs (India) Ltd (PDIL) has chalked out a Rs 50-crore expansion plan for its Baddi unit in Himachal Pradesh.
 
"We enjoy an excise tax holiday for 10 years in Baddi. We have invested Rs 35 crore in the facility and are going to create an additional capacity with an investment of Rs 50 crore, including modernisation of our Indore units," said Anil Mittal, chief executive officer of the company.
 
PDIL started its unit in Indore to manufacture intravenous (IV) fluids in polypropylene bottles against glass bottles and further diversified into eye and ear drops and formulations (solid and liquid orals). The company set up its unit in Baddi industrial area last year for formulations; injectibles tablets and capsules.
 
"Since Indore is centrally located and freight does matter in IV fluid that is why we have decided to have our formulation unit in Baddi and IV fluid unit in Indore," he added.
 
The IV fluid is an excise free commodity. He also said that his company was gauging potential in export market.
 
"Currently 10-15 per cent of our business comes from exports but we are looking at some international-level recognition for our products," Mittal further said.

 
image

Latest News